Skip to main content
A-LevelBiologyGenetic technology9700/42 · May/June 2020 · Q410 Marks

Gene therapy can be used to treat some genetic disorders. An appropriate vector is chosen to carry the normal allele into the target cell. Three types of vectors commonly chosen are naked DNA, viruses and liposomes.

  1. (a)A trial of gene therapy to treat cystic fibrosis used a viral vector. The viral vector caused a primary immune response with the production of memory cells. Explain why the production of memory cells prevents the gene therapy from working in long-term chronic conditions such as cystic fibrosis.[3]
  2. (b)With reference to the three types of vectors that are commonly used, discuss the challenges in choosing appropriate vectors for use in gene therapy. Do not include problems associated with an immune response in your answer.[4]
  3. (c)(i)A trial was carried out to find a new vector for use in gene therapy. The new vector was made from red blood cells taken from the person with the genetic disorder. The cells had most of their cytoplasmic content removed and were then broken up to make small spherical vectors. Most of these vectors lacked the ability to bind to receptors on the target cells. To solve this problem, genetically engineered stem cells taken from the person were used to form red blood cells. These red blood cells had membrane proteins that were complementary to the target cell receptors. The vectors that were produced were well-tolerated by the immune system. Explain why the vectors were well-tolerated by the immune system.[2]
  4. (c)(ii)Suggest why it is not possible to produce genetically engineered red blood cells, except by using genetically engineered stem cells.[1]

Mark scheme

Marking points from the official mark scheme (May/June 2020). The mark or mark type is shown in brackets.

  1. [3] any three from:
  2. 1 repeat treatment causes, bigger/more rapid, immune response ;
  3. 2 (so) target cells (expressing new protein) short-lived / AW ;
  4. 3 decrease in (trans)gene expression on re-administration;
  5. 4 AVP; e.g. ref. to antibody binding / antibodies attract phagocytes
  6. [4] any four from:
  7. naked DNA
  8. 1 has to be injected into target cell / lack of organ-specific delivery;
  9. 2 low efficiency of cellular uptake;
  10. 3 rapidly broken down ;
  11. viruses
  12. 4 small packaging capacity / only small amount of DNA can be carried;
  13. 5 low probability of integration (into host genome) ;
  14. 6 cause mutations in host DNA / (gene) insertion disrupts gene function / insertional mutagenesis ;
  15. liposomes
  16. 7 low ability to, add DNA/ genes, into target cells (genome) / low transduction efficiency;
  17. [2] 1 red blood cells had 'self' antigens ;
  18. 2 not recognised as foreign;
  19. [1] (red blood cell) has no nucleus so no, DNA / transcription / translation, of targeting proteins; ora

Write your answer and get it marked

On Oracle Prep you can write or photograph your own answer and have it marked by AI against this mark scheme, with feedback on what you missed.

Sign up free →

About this question

Topic
Genetic technology, A-Level Biology (syllabus 9700). Structured question, 10 marks.
Source
A-Level Biology, May/June 2020 Paper 4 Variant 2, question 4.

Questions and mark schemes are from past examination papers and remain the copyright of the exam board. How Oracle Prep builds its content

Related Biology questions

© 2026 Oracle Prep